1. Home
  2. PLAB vs IMNM Comparison

PLAB vs IMNM Comparison

Compare PLAB & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Photronics Inc.

PLAB

Photronics Inc.

HOLD

Current Price

$34.73

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$19.99

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLAB
IMNM
Founded
1969
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
1987
2020

Fundamental Metrics

Financial Performance
Metric
PLAB
IMNM
Price
$34.73
$19.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$43.50
$31.44
AVG Volume (30 Days)
2.2M
3.1M
Earning Date
02-25-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
9.09
N/A
EPS
2.28
N/A
Revenue
$849,294,000.00
$9,679,000.00
Revenue This Year
$7.61
N/A
Revenue Next Year
$7.50
$11.53
P/E Ratio
$15.44
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.46
$5.15
52 Week High
$39.80
$25.30

Technical Indicators

Market Signals
Indicator
PLAB
IMNM
Relative Strength Index (RSI) 62.92 49.20
Support Level $31.93 $19.15
Resistance Level $35.77 $21.67
Average True Range (ATR) 1.35 1.20
MACD -0.28 -0.36
Stochastic Oscillator 75.13 24.85

Price Performance

Historical Comparison
PLAB
IMNM

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company principally engaged in the manufacturing of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of integrated circuits (ICs) and flat-panel displays (FPDs) and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during fabrication, as well as to a lesser extent, other types of electrical and optical components. The Company has manufacturing facilities in Taiwan, China, South Korea, the United States, and Europe, and generates revenue globally, with Taiwan contributing the majority of total revenue.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: